Name Net increased
positions
Increased positions Reduced positions Return since
30 Jun ‘24
876
29 100 71 45.6%
877
29 32 3 2.7%
878
29 72 43 102%
ALNY icon
879
Alnylam Pharmaceuticals
ALNY
$43B
29 194 165 37%
880
29 71 42 44.7%
881
29 39 10 22%
882
29 353 324 34%
883
29 65 36 15.2%
884
29 112 83 37.4%
885
29 47 18 63.9%
NMRA icon
886
Neumora Therapeutics
NMRA
$371M
29 42 13 79%
887
29 338 309 46.2%
888
29 49 20 1.79%
889
29 390 361 115%
890
29 55 26 15%
891
29 59 30 439%
892
29 108 79 0.96%
893
29 91 62 95%
894
29 93 64 51.9%
895
29 117 88 33%
896
29 29 0 13.4%
897
29 88 59 42.2%
898
29 87 58 29.7%
899
29 223 194 31.3%
900
29 47 18 251%